Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative

12 Apr 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dementia and Cognitive Impairment Research
Share to Health, Environment, Cognitive Aging
Share to Health Systems, Economic Evaluations, Quality of Life

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22503160
DOI: 10.1016/j.neurobiolaging.2012.03.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging InitiativePMID 22503160Read ↗

Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's diseaseSemantic proximity Read ↗

Clinical trials in predementia stages of Alzheimer disease.Semantic proximity Read ↗

Use of preclinical Alzheimer’s disease trajectories for clinical trial designSemantic proximity Read ↗

Choosing Alzheimer's disease prevention clinical trial populations.Semantic proximity Read ↗

Effect of <i>APOE</i> genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's diseaseSemantic proximity Read ↗

Racial and Ethnic Reporting and Representation in Phase III Alzheimer’s Disease Clinical Trials in the USSemantic proximity Read ↗

The Oxford Brain Health Clinic: Protocol and Research DatabaseSemantic proximity Read ↗

Development of Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD)Semantic proximity Read ↗

The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial.Semantic proximity Read ↗

Using Historical Data to Facilitate Clinical Prevention Trials in Alzheimer Disease?Semantic proximity Read ↗

Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trialSemantic proximity Read ↗

Using a Distribution-Based Approach and Systematic Review Methods to Derive Minimum Clinically Important DifferencesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.